Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Buhles

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Veterinary Research|June 1, 1977
Studies on the pathogenesis of Rickettsia rickettsii in the dog: clinical and clinicopathologic changes of experimental infectionK P Keenan, W C Buhles, D L Huxsoll, et al.
Cancer|November 1, 1977
Chemoimmunotherapy for canine lymphosarcomaS E Crow, G H Theilen, E Benjaminini, et al.
Annals of Internal Medicine|February 1, 1993
Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trialD J Winston, W G Ho, K Bartoni, et al.
Journal of Clinical Pharmacology|March 1, 1996
Effect of food on the relative bioavailability of oral ganciclovirJ Lavelle, S Follansbee, C B Trapnell, et al.
Reviews of Infectious Diseases|July 1, 1988
Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal functionJ P Sommadossi, R Bevan, T Ling, et al.
The Journal of Infectious Diseases|June 1, 1977
Pathogenesis of infection with Rickettsia rickettsii in the dog: a disease model for Rocky Mountain spotted feverK P Keenan, W C Buhles, D L Huxsoll, et al.
Reviews of Infectious Diseases|July 1, 1988
Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipientsS Keay, E Petersen, T Icenogle, et al.
The New England Journal of Medicine|December 5, 1991
Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantationJ M Goodrich, M Mori, C A Gleaves, et al.
Blood|June 15, 1994
Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemiaJ Nemunaitis, F R Appelbaum, K Lilleby, et al.
The Journal of Infectious Diseases|April 11, 1991
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infectionW L Drew, R C Miner, D F Busch, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Veterinary Research|June 1, 1977
Studies on the pathogenesis of Rickettsia rickettsii in the dog: clinical and clinicopathologic changes of experimental infectionK P Keenan, W C Buhles, D L Huxsoll, et al.
Cancer|November 1, 1977
Chemoimmunotherapy for canine lymphosarcomaS E Crow, G H Theilen, E Benjaminini, et al.
Annals of Internal Medicine|February 1, 1993
Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trialD J Winston, W G Ho, K Bartoni, et al.
Journal of Clinical Pharmacology|March 1, 1996
Effect of food on the relative bioavailability of oral ganciclovirJ Lavelle, S Follansbee, C B Trapnell, et al.
Reviews of Infectious Diseases|July 1, 1988
Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal functionJ P Sommadossi, R Bevan, T Ling, et al.
The Journal of Infectious Diseases|June 1, 1977
Pathogenesis of infection with Rickettsia rickettsii in the dog: a disease model for Rocky Mountain spotted feverK P Keenan, W C Buhles, D L Huxsoll, et al.
Reviews of Infectious Diseases|July 1, 1988
Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipientsS Keay, E Petersen, T Icenogle, et al.
The New England Journal of Medicine|December 5, 1991
Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantationJ M Goodrich, M Mori, C A Gleaves, et al.
Blood|June 15, 1994
Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemiaJ Nemunaitis, F R Appelbaum, K Lilleby, et al.
The Journal of Infectious Diseases|April 11, 1991
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infectionW L Drew, R C Miner, D F Busch, et al.
Pageof 2